# Shanzhen

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shanzhen

- Industry: Healthcare
- Headquarters: Shanghai, China
- Website: www.shanzhen.me
- Total disclosed funding: $8.6M
- Latest round: Series D (Jun 1, 2019)
- Investors on record: 4

## About

Shanzhen is a health management company specializing in integrated health management services for organizations and individuals, focusing on preventative health examinations and tailored wellness solutions.Founded in 2014 in Shanghai, China, Shanzhen operates in the health management sector, providing comprehensive health services. The company has successfully completed five deals, with the latest being a Series A funding round in June 2019, where it raised USD 7.00 mn from Jiyuan Capital. Hongxing Wu is the CEO of the company.Shanzhen offers comprehensive health management solutions that include integrated health management center services for both corporate clients and individuals. Their core focus is on preventative health examinations and customized corporate health management services to meet the rising demand for health services in workplaces. The company serves various sectors, enhancing employee wellness by providing health check-up plans and tailored health resources. Shanzhen aims to address the needs of clients seeking timely health assessments and ongoing management, promoting proactive health behaviors among employees and individuals alike.Shanzhen's revenue model is based on direct sales of health services and corporate partnerships. The company engages in customized contracts with corporate clients, which often include bulk purchasing agreements for annual health check-ups and ongoing management plans. This structured approach facilitates recurring revenue streams from long-term partnerships and positions Shanzhen as a significant player in the health examination market, offering various tailored health examination packages to meet specific client needs.Shanzhen plans to expand its product offerings and launch new health management solutions in the upcoming year. The company is targeting regional expansions into broader markets across Asia by 2024. The recent funding from the Series A round will be utilized to support these initiatives and enhance Shanzhen's capacity to deliver comprehensive health management solutions. In June 2019, Shanzhen raised USD 7.00 mn in its latest funding round to bolster these growth strategies.

## Funding rounds

- Series D, Jun 1, 2019 — Hillhouse Investment
- Series B, May 21, 2019 — BlueRun Ventures, SIG Asia Investment, Jiyuan Capital
- Series B, Apr 1, 2018 — SIG Asia Investment
- Series A, Apr 30, 2016, $7M — Jiyuan Capital
- Angel, Apr 1, 2015, $1.6M — BlueRun Ventures

## Investors

- BlueRun Ventures (https://capitalatlas.ai/funds/bluerun-ventures) — Angel, Series B
- Jiyuan Capital (https://capitalatlas.ai/funds/jiyuan-capital) — Series A, Series B
- SIG Asia Investment (https://capitalatlas.ai/funds/sig-asia-investment) — Series B
- Hillhouse Investment (https://capitalatlas.ai/funds/hillhouse-investment) — Series D